Interestingly, tumors derived from animals treated with Rac1 inhibitor showed an increased number of immune cell infiltrates suggesting that Rac1 inhibition could be acting through different mechanisms, including immune escape mediated by tumor microenvironment [91]. Here, RAC1 is linked to neoplasm.